Form 4: Stuart Diamond Receives Restricted Stock Grant in bioAffinity Technologies, Inc.
SEC Form 4 Filing
Director Stuart Diamond received a grant of 8,296 restricted shares of bioAffinity Technologies, Inc. common stock that vest immediately.
Summary
- On June 12, 2024, Stuart Diamond, a director of bioAffinity Technologies, Inc. (BIAF), acquired 8,296 shares of common stock.
- These shares were granted as restricted stock and vest immediately.
- Following the transaction, Diamond's direct ownership in BIAF common stock is 65,304 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, and the sentiment is neutral.
Positives
- The grant of restricted stock to a director could align their interests with those of the shareholders.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder confidence due to the alignment of director interests.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: Stuart Diamond acquired restricted shares. |
| 06/14/2024 | Date of signature on the Form 4 filing. |
Keywords
bioAffinity Technologies, Stuart Diamond, restricted stock, BIAF, Form 4, beneficial ownership, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.